Brain tumor medical therapy

Revision as of 21:05, 30 November 2012 by Charmaine Patel (talk | contribs)
Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Brain tumor Microchapters

Patient Information

Overview

Classification

Adult brain tumors
Glioblastoma multiforme
Oligodendroglioma
Meningioma
Hemangioblastoma
Pituitary adenoma
Schwannoma
Primary CNS lymphoma
Childhood brain tumors
Pilocytic astrocytoma
Medulloblastoma
Ependymoma
Craniopharyngioma
Pinealoma
Metastasis
Lung cancer
Breast cancer
Melanoma
Gastrointestinal tract cancer
Renal cell carcinoma
Osteoblastoma
Head and neck cancer
Neuroblastoma
Lymphoma
Prostate cancer

Causes

Differentiating Brain Tumor from other Diseases

Overview

Although there is no generally accepted therapeutic management for primary brain tumors, a surgical attempt at tumor removal or at least cytoreduction (that is, removal of as much tumor as possible, in order to reduce the number of tumor cells available for proliferation) is considered in most cases[1]. However, due to the infiltrative nature of these lesions, tumor recurrence, even following an apparently complete surgical removal, is not uncommon. Postoperative radiotherapy and chemotherapy are integral parts of the therapeutic standard for malignant tumors. Radiotherapy may also be administered in cases of "low-grade" gliomas, when a significant tumor burden reduction could not be achieved surgically.

Chemotherapy may be used with surgery or radiation treatment.

Medical Therapy

Some drugs that are used t treat Brain Cancer are:

Everolimus- FDA approved - approved to treat Subependymal giant cell astrocytoma in patients who have Tuberous Sclerosis and are not able to have surgery. Bevacizumab- FDA approved - approved to treat Glioblastoma in patients whose disease has not gotten better with other types of treatment.

Lomustine- FDA approved - used in patients who have already had surgery or radiation therapy

Temozolomide- FDA approved - used in adults for the treatment of Anaplatic astrocytomas and Glioblastoma multiforme

Other medications used to treat primary brain tumors in children may include:

  • Corticosteroids, such as dexamethasone, to reduce brain swelling
  • Medicines such as urea or mannitol to reduce brain swelling and pressure
  • Anticonvulsants, such as evetiracetam (Keppra), to reduce seizures
  • Pain medications
  • Antacids or histamine blockers to control

Comfort measures, safety measures, physical therapy, and occupational therapy may be needed to improve quality of life. Counseling, support groups, and similar measures can help people cope with the disorder.

Radiation Therapy

In case of a malignant brain tumor, radiation therapy is needed to control the tumor and possibly acheive long-term remission. There are some possible side effects of radiation therapy; these include the possibility of strokes and Dementia. The severity as well as the chance that they happen, worsen with higher doses of therapy. The radiation therapy is usually very well tolerated.

Stereotactic Radiosurgery:

Stereotactic radiosurgery is a special form of radiation therapy - it is not surgery. Stereotactic radiosurgery allows precisely focused, high dose X-ray beams to be delivered to a small, localized area of the brain. It is used to treat small brain and spinal cord tumors (both benign and malignant); blood vessel abnormalities in the brain; defined areas of cancer; certain small tumors in the lungs and liver; and neurologic problems such as movement disorders.Stereotactic radiosurgery is given in a single session. If given in multiple sessions, the treatment may be called stereotactic radiotherapy or fractionated stereotactic radiotherapy. “Frameless radiosurgery” refers to radiosurgery that does not use a metal frame to immobilize the head during treatment. Rather, markers able to be viewed on a scan are placed on the scalp, or a face mask is used to help hold the head steady. The treatment equipment is then aligned with the markers or with the face mask.

Radiosurgery is different from Conventional Radiation therapy. Conventional external beam radiation therapy – the most common form of radiation therapy – delivers full dose radiation to the tumor and some of the surrounding brain tissue. For several reasons, the target area for conventional radiation deliberately includes a border (called a “margin”) of normal brain around the tumor. These reasons include uneven tumor borders, the risk of invisible spread of the tumor into the surrounding tissue, a larger tumor size, or the presence of multiple tumors. This larger zone of full-dose radiation includes the borders of the tumor where microscopic tumor cells may be located. Since normal brain tissue is included in the full-dose region, conventional radiation is broken down into small daily doses so the normal brain tissue can tolerate it. As a result, reaching the desired dose of radiation takes several weeks of daily treatment. Radiosurgery focuses radiation beams more closely to the tumor than conventional external beam radiation. This is possible through the use of highly sophisticated computer-assisted equipment. A head frame or facemask used for this treatment allows very precise set up, localization and treatment of the tumor. Using advanced computer planning, radiosurgery minimizes the amount of radiation received by normal brain tissue and focuses radiation in the area to be treated. Since conventional radiation therapy covers more normal tissue, it can often be given only once. Radiosurgery, however, may be considered for re-irradiation due to its precision and the possibility of avoiding previously treated areas

Gamma knife, Linear Accelerators, Proton Beam radiosurgery units are the types of equipment used in Radiosurgery. Radiosurgery requires a team of specialists. That team may include a neurosurgeon, radiation oncologist, radiologist, radiation physicist, neurologist, anesthesiologist, specially trained nurses, technologists and the unit support staff.The actual treatment time for any of these techniques generally ranges from 15 minutes to about two hours.

Some people have few or no side effects from this type of radiation therapy. Once they have rested following the treatment and have resumed their regular activities, tenderness at the pin sites may be the only side effect Early symptoms are often due to brain edema (swelling) caused by the radiation. These symptoms can include nausea, vomiting, dizziness, or headaches which are usually temporary. Once the swelling resolves, these symptoms usually resolve. Two to three weeks after treatment, some may experience hair loss in the area radiated, but this does not occur in everyone. Hair loss depends on the dose of radiation received by portions of the scalp and the ability of the radiated hair follicles to heal. Regrowth usually begins in 3-4 months, and may be a slightly different color or texture than before. The scalp may also become temporarily irritated. Some patients may experience delayed reactions weeks or months after treatment. These reactions can include necrosis or cell death in the high radiation dose region due to swelling in reaction to the radiation effect on the target region. These symptoms are mainly due to swelling or death of brain tissue in the treated area. They may mimic the symptoms of tumor regrowth or stroke. Treatment will be based on the type of side effect that occurred. Other effects depend on the location of the tumor.

References

  1. Nakamura M, Konishi N, Tsunoda S, Nakase H, Tsuzuki T, Aoki H, Sakitani H, Inui T, Sakaki T. Analysis of prognostic and survival factors related to treatment of low-grade astrocytomas in adults. Oncology 2000;58:108-16. PMID 10705237.

Template:WH Template:WS